Washington – The Ministry of Health and Humanitarian Services will cancel contracts and withdraw funding for some vaccines that are developed to combat respiratory viruses such as Covid-19 and influenza.
Note: The video is from a previous report.
Robert F. Kennedy Junior in a statement on Tuesday that 22 projects will be stopped, totaling $ 500 million, to develop vaccines using the Mercy Rana technology.
The Minister of Health and Humanitarian Services, Robert F. Kennedy Junior during an event in the Eastern Chamber of the White House, Wednesday, July 30, 2025, in Washington.
AP Photo/Mark Schiesfelbein
Kennedy’s decision to end the projects is the latest in a series of decisions that have long been doubts of the vaccine critic about the bullets in its full impact on the country’s Ministry of Health. Kennedy withdrew recommendations about Covid-19 shots, launched the painting that provides vaccine recommendations, and refused to provide strong support for the vaccine with the exacerbation of the measles outbreak.
The Minister of Health criticized the Al-Morsal Rana vaccines in a video clip of his social media accounts, and explained the decision to cancel the projects led by leading pharmaceutical companies in the country, including Pfizer and Moderna, which provides protection against viruses such as influenza, Covid-19 and H5N1.
Kennedy said in the video: “To replace the troubled Marna programs, we are priority to develop safer and broader vaccine strategies, such as full virus vaccines and new platforms that do not collapse when viruses turn.”
Infectious diseases experts say the technology of the Merseuled Rana used in vaccines is safe, and they refer to its development during the first Trump administration while slowing the Korona 2020 virus. They warned of future epidemics, difficult to stop without the help of the Mercy Rana.
“I don’t think I have seen a more dangerous decision in public health during the fifty years at work,” said Mike Ostohm, a Minnesota University expert in infectious diseases and friendly preparations.
He pointed out that the MRNA technology provides possible advantages of rapid production, and it is decisive in the event of a new pandemic that requires a new vaccine.
Dr. Paul Ofit, a vaccine expert at the Children’s Hospital in Philadelphia, said that the shelves of flexible projects are short -sighted, while continuing concerns about the pandemic of bird influenza on the horizon.
“Certainly saved millions of lives,” Ofit said of the current Merna vaccines.
Scientists use more than more than infectious diseases, as researchers around the world explore its use of immunotherapy for cancer. In the White House earlier this year, the billionaire technology pioneer, Larry Ellison, praised his ability to treat cancer.
Traditionally, vaccines require increased pieces of viruses, often in chicken eggs or giant cells, then purify that substance. A flexible approach begins with an excerpt from the genetic code that carries instructions to make proteins. Scientists choose protein to target, injecting this scheme and body makes just enough to cause immune protection – the production of its vaccine dose.
In a statement on Tuesday, HHS said, “The other uses of a flexible technology within the department are not affected by this advertisement.”
A flexible technique is used in COVID-19 and RSV shots, but it has not yet been approved for influenza snapshot. Moderna, who was studying the Covid-19 and Flu Mrna collection, said it believed that a flexible can accelerate the production of influenza shots compared to traditional vaccines.
In its statement, the Ministry of Health said, adding that it will start “investing in better solutions.”
“Let me be completely clear, HHS supports safe and effective vaccines for every American he wants,” Kennedy said in the statement.
Hours after speaking on Tuesday at an Ankarag press conference, Alaska, along with Republican Senators in the United States, Kennedy said that work is underway in an alternative.
He said that a “global vaccine” mimics “natural immunity” is the concentration of management.
“This may be effective – we think it will be effective – not only Coronav viruses, but also influenza,” he said.
–
The authors of the Associated Press Laurent Nergard in Washington and Mike Stop contributed to New York and Bakik Bohred in Juno.
Copyright © 2025 by Associated Press. All rights reserved.